Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
230.1 USD | +0.00% | -7.44% | -3.52% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.52% | 11.82B | |
-1.79% | 41.36B | |
+44.87% | 41.3B | |
+1.59% | 39.61B | |
-15.14% | 25.62B | |
+3.02% | 24.09B | |
-23.55% | 18.38B | |
+23.34% | 11.85B | |
+7.44% | 11.07B | |
-19.95% | 9.86B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories International : Citigroup Downgrades Charles River to Neutral From Buy, Adjusts Price Target to $250 From $270